class name | count |
---|
class name | count |
---|---|
Streptomycetaceae | 3 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00018664
![]() |
Mitomycin B
|
CHEMBL323536
|
![]() |
|||
C00018665
![]() |
NSC 75986
/ Mitomycin A |
CHEMBL298359
|
C046000
|
0 / 1 |
![]() |
|
C00018668
![]() |
MMC
/ Mitonco / Mitoplus / Mitocin C / Mutamycin / Ametycine / NSC 26980 / Mitomycin / Mitomycin C |
CHEMBL105
CHEMBL518494 CHEMBL1354559 CHEMBL1518783 |
D016685
|
113 / 67 / 74 | 239 / 127 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00018668 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00018668 | 7 / 37 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00018668 | 4 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00018668 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00018668 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00018668 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00018668 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00018668 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00018668 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00018668 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00018668 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00018668 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00018668 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00018668 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00018668 | 2 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00018668 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00018668 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00018668 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00018668 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00018668 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00018668 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00018668 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00018668 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00018668 | 0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00018668 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00018668 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00018668 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00018668 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00018668 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00018668 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00018668 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00018668 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00018668 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00018668 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00018668 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00018668 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00018668 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00018668 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00018668 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00018668 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00018668 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00018668 | 0 / 0 |
P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00018668 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00018668 | 1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00018668 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00018668 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00018668 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00018668 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00018668 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00018668 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00018668 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00018668 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00018668 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00018668 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00018668 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00018668 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00018668 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00018668 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00018668 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00018668 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00018668 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00018668 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00018668 | 7 / 3 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00018668 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00018668 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00018668 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00018668 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00018668 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00018668 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00018668 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00018668 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00018668 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00018668 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00018668 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00018668 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00018668 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00018668 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00018668 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00018668 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00018668 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00018668 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00018668 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00018668 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00018668 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00018668 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00018668 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00018668 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00018668 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00018668 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00018668 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00018668 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00018668 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00018668 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00018668 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00018668 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00018668 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00018668 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00018668 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00018668 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00018668 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00018668 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00018668 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00018668 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00018668 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00018668 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00018668 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00018668 | 1 / 1 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00018668 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00018668 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00018668 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00018668 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00018668 | 1 / 4 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00018668 | 0 / 3 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00018668
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00018668
|
3983 | ABLIM1, ABLIM, LIMAB1, LIMATIN, abLIM-1 | actin binding LIM protein 1 |
C00018668
|
48 | ACO1, ACONS, IREB1, IREBP, IREBP1, IRP1 | aconitase 1, soluble (EC:4.2.1.3) |
C00018668
|
10965 | ACOT2, CTE-IA, CTE1A, MTE1, PTE2, PTE2A, ZAP128 | acyl-CoA thioesterase 2 (EC:3.1.2.2) |
C00018668
|
2180 | ACSL1, ACS1, FACL1, FACL2, LACS, LACS1, LACS2 | acyl-CoA synthetase long-chain family member 1 (EC:6.2.1.3) |
C00018668
|
2181 | ACSL3, ACS3, FACL3, PRO2194 | acyl-CoA synthetase long-chain family member 3 (EC:6.2.1.3) |
C00018668
|
10768 | AHCYL1, DCAL, IRBIT, PRO0233, XPVKONA | adenosylhomocysteinase-like 1 (EC:3.3.1.1) |
C00018668
|
9590 | AKAP12, AKAP250, SSeCKS | A kinase (PRKA) anchor protein 12 |
C00018668
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00018668
|
214 | ALCAM, CD166, MEMD | activated leukocyte cell adhesion molecule |
C00018668
|
218 | ALDH3A1, ALDH3, ALDHIII | aldehyde dehydrogenase 3 family, member A1 (EC:1.2.1.5) |
C00018668
|
316 | AOX1, AO, AOH1 | aldehyde oxidase 1 (EC:1.2.3.1) |
C00018668
|
327 | APEH, AARE, ACPH, APH, D3F15S2, D3S48E, DNF15S2, OPH | acylaminoacyl-peptide hydrolase (EC:3.4.19.1) |
C00018668
|
328 | APEX1, APE, APE1, APEN, APEX, APX, HAP1, REF1 | APEX nuclease (multifunctional DNA repair enzyme) 1 (EC:4.2.99.18) |
C00018668
|
27350 | APOBEC3C, A3C, APOBEC1L, ARDC2, ARDC4, ARP5, PBI, bK150C2.3 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C |
C00018668
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00018668
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00018668
|
468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00018668
|
476 | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) |
C00018668
|
546 | ATRX, ATR2, JMS, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX | alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12) |
C00018668
|
60370 | AVPI1, PP5395, RP11-548K23.7, VIP32, VIT32 | arginine vasopressin-induced 1 |
C00018668
|
25825 | BACE2, AEPLC, ALP56, ASP1, ASP21, BAE2, CEAP1, DRAP | beta-site APP-cleaving enzyme 2 (EC:3.4.23.45) |
C00018668
|
572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death |
C00018668
|
25805 | BAMBI, NMA | BMP and activin membrane-bound inhibitor |
C00018668
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00018668
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00018668
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00018668
|
55909 | BIN3 | bridging integrator 3 |
C00018668
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00018668
|
652 | BMP4, BMP2B, BMP2B1, MCOPS6, OFC11, ZYME | bone morphogenetic protein 4 |
C00018668
|
93664 | CADPS2 | Ca++-dependent secretion activator 2 |
C00018668
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00018668
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00018668
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00018668
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00018668
|
56267 | CCBL2, KAT3, KATIII, RP4-531M19.2 | cysteine conjugate-beta lyase 2 (EC:2.6.1.7 4.4.1.13 2.6.1.63) |
C00018668
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00018668
|
891 | CCNB1, CCNB | cyclin B1 |
C00018668
|
966 | CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20 | CD59 molecule, complement regulatory protein |
C00018668
|
928 | CD9, BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29 | CD9 molecule |
C00018668
|
978 | CDA, CDD | cytidine deaminase (EC:3.5.4.5) |
C00018668
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00018668
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00018668
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00018668
|
9702 | CEP57, MVA2, PIG8, TSP57 | centrosomal protein 57kDa |
C00018668
|
26511 | CHIC2, BTL | cysteine-rich hydrophobic domain 2 |
C00018668
|
1159 | CKMT1B, CKMT, CKMT1, UMTCK | creatine kinase, mitochondrial 1B (EC:2.7.3.2) |
C00018668
|
1047 | CLGN | calmegin |
C00018668
|
1690 | COCH, COCH-5B2, COCH5B2, DFNA9, DFNA31 | cochlin |
C00018668
|
1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 |
C00018668
|
1299 | COL9A3, DJ885L7.4.1, EDM3, IDD, MED | collagen, type IX, alpha 3 |
C00018668
|
10063 | COX17 | COX17 cytochrome c oxidase copper chaperone |
C00018668
|
1373 | CPS1, CPSASE1, PHN | carbamoyl-phosphate synthase 1, mitochondrial (EC:6.3.4.16) |
C00018668
|
10217 | CTDSPL, C3orf8, HYA22, PSR1, RBSP3, SCP3 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like (EC:3.1.3.16) |
C00018668
|
1495 | CTNNA1, CAP102 | catenin (cadherin-associated protein), alpha 1, 102kDa |
C00018668
|
6374 | CXCL5, ENA-78, SCYB5 | chemokine (C-X-C motif) ligand 5 |
C00018668
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00018668
|
64421 | DCLRE1C, A-SCID, DCLREC1C, RS-SCID, SCIDA, SNM1C, hSNM1C | DNA cross-link repair 1C |
C00018668
|
1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00018668
|
1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00018668
|
54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00018668
|
780 | DDR1, CAK, CD167, DDR, EDDR1, HGK2, MCK10, NEP, NTRK4, PTK3, PTK3A, RTK6, TRKE | discoidin domain receptor tyrosine kinase 1 (EC:2.7.10.1) |
C00018668
|
27122 | DKK3, REIC, RIG | dickkopf WNT signaling pathway inhibitor 3 |
C00018668
|
1756 | DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272 | dystrophin |
C00018668
|
10589 | DRAP1, NC2-alpha | DR1-associated protein 1 (negative cofactor 2 alpha) |
C00018668
|
29940 | DSE, DSEP, DSEPI, SART-2, SART2 | dermatan sulfate epimerase (EC:5.1.3.19) |
C00018668
|
1846 | DUSP4, HVH2, MKP-2, MKP2, TYP | dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) |
C00018668
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00018668
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00018668
|
9669 | EIF5B, IF2 | eukaryotic translation initiation factor 5B |
C00018668
|
2004 | ELK3, ERP, NET, SAP2 | ELK3, ETS-domain protein (SRF accessory protein 2) |
C00018668
|
2013 | EMP2, XMP | epithelial membrane protein 2 |
C00018668
|
1969 | EPHA2, ARCC2, CTPA, CTPP1, CTRCT6, ECK | EPH receptor A2 (EC:2.7.10.1) |
C00018668
|
2065 | ERBB3, ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (EC:2.7.10.1) |
C00018668
|
405754 | ERVFRD-1, ERVFRDE1, GLLL6191, HERV-FRD, HERV-W/FRD, UNQ6191, envFRD | endogenous retrovirus group FRD, member 1 |
C00018668
|
2149 | F2R, CF2R, HTR, PAR-1, PAR1, TR | coagulation factor II (thrombin) receptor |
C00018668
|
116496 | FAM129A, C1orf24, NIBAN | family with sequence similarity 129, member A |
C00018668
|
221061 | FAM171A1, C10orf38 | family with sequence similarity 171, member A1 |
C00018668
|
55603 | FAM46A, C6orf37, XTP11 | family with sequence similarity 46, member A |
C00018668
|
22909 | FAN1, KIAA1018, KMIN, MTMR15 | FANCD2/FANCI-associated nuclease 1 (EC:3.1.4.1) |
C00018668
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00018668
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00018668
|
2195 | FAT1, CDHF7, CDHR8, FAT, ME5, hFat1 | FAT atypical cadherin 1 |
C00018668
|
2091 | FBL, FIB, FLRN, RNU3IP1 | fibrillarin |
C00018668
|
2222 | FDFT1, DGPT, ERG9, SQS, SS | farnesyl-diphosphate farnesyltransferase 1 (EC:2.5.1.21) |
C00018668
|
2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00018668
|
2273 | FHL1, FHL-1, FHL1A, FHL1B, FLH1A, KYOT, SLIM, SLIM-1, SLIM1, SLIMMER, XMPMA | four and a half LIM domains 1 |
C00018668
|
51024 | FIS1, TTC11 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
C00018668
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00018668
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00018668
|
50486 | G0S2, RP1-28O10.2 | G0/G1switch 2 |
C00018668
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00018668
|
2579 | GAGE7, AL4, CT4.7, GAGE-7 | G antigen 7 |
C00018668
|
9289 | GPR56, BFPP, TM7LN4, TM7XN1 | G protein-coupled receptor 56 |
C00018668
|
29899 | GPSM2, CMCS, DFNB82, LGN, PINS | G-protein signaling modulator 2 |
C00018668
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00018668
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00018668
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00018668
|
3059 | HCLS1, CTTNL, HS1 | hematopoietic cell-specific Lyn substrate 1 |
C00018668
|
9734 | HDAC9, HD7, HD7b, HD9, HDAC, HDAC7, HDAC7B, HDAC9B, HDAC9FL, HDRP, MITR | histone deacetylase 9 (EC:3.5.1.98) |
C00018668
|
23462 | HEY1, BHLHb31, CHF2, HERP2, HESR1, HRT-1, OAF1, hHRT1 | hes-related family bHLH transcription factor with YRPW motif 1 |
C00018668
|
3087 | HHEX, HEX, HMPH, HOX11L-PEN, PRH, PRHX | hematopoietically expressed homeobox |
C00018668
|
3107 | HLA-C, D6S204, HLA-JY3, HLC-C, PSORS1 | major histocompatibility complex, class I, C |
C00018668
|
10362 | HMG20B, BRAF25, BRAF35, HMGX2, HMGXB2, PP7706, SMARCE1r, SOXL, pp8857 | high mobility group 20B |
C00018668
|
3159 | HMGA1, HMG-R, HMGA1A, HMGIY | high mobility group AT-hook 1 |
C00018668
|
8091 | HMGA2, BABL, HMGI-C, HMGIC, LIPO, STQTL9 | high mobility group AT-hook 2 |
C00018668
|
3312 | HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, NIP71 | heat shock 70kDa protein 8 |
C00018668
|
23463 | ICMT, HSTE14, MST098, MSTP098, PCCMT, PCMT, PPMT | isoprenylcysteine carboxyl methyltransferase (EC:2.1.1.100) |
C00018668
|
3400 | ID4, IDB4, bHLHb27 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
C00018668
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00018668
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00018668
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00018668
|
3613 | IMPA2 | inositol(myo)-1(or 4)-monophosphatase 2 (EC:3.1.3.25) |
C00018668
|
221037 | JMJD1C, RP11-10C13.2, TRIP8 | jumonji domain containing 1C |
C00018668
|
23189 | KANK1, ANKRD15, CPSQ2, KANK | KN motif and ankyrin repeat domains 1 |
C00018668
|
23254 | KAZN, KAZ | kazrin, periplakin interacting protein |
C00018668
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00018668
|
3897 | L1CAM, CAML1, CD171, HSAS, HSAS1, MASA, MIC5, N-CAM-L1, N-CAML1, NCAM-L1, S10, SPG1 | L1 cell adhesion molecule |
C00018668
|
3958 | LGALS3, CBP35, GAL3, GALBP, GALIG, L31, LGALS2, MAC2 | lectin, galactoside-binding, soluble, 3 |
C00018668
|
3978 | LIG1 | ligase I, DNA, ATP-dependent (EC:6.5.1.1) |
C00018668
|
22998 | LIMCH1, LIMCH1A, LMO7B | LIM and calponin homology domains 1 |
C00018668
|
9516 | LITAF, PIG7, SIMPLE, TP53I7 | lipopolysaccharide-induced TNF factor |
C00018668
|
4000 | LMNA, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, FPLD2, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1 | lamin A/C |
C00018668
|
4053 | LTBP2, C14orf141, GLC3D, LTBP3, MSPKA, MSTP031, WMS3 | latent transforming growth factor beta binding protein 2 |
C00018668
|
4111 | MAGEA12, CT1.12, MAGE12 | melanoma antigen family A, 12 |
C00018668
|
4102 | MAGEA3, CT1.3, HIP8, HYPD, MAGE3, MAGEA6 | melanoma antigen family A, 3 |
C00018668
|
4105 | MAGEA6, CT1.6, MAGE-3b, MAGE3B, MAGE6 | melanoma antigen family A, 6 |
C00018668
|
4116 | MAGOH, MAGOH1, MAGOHA | mago-nashi homolog, proliferation-associated (Drosophila) |
C00018668
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00018668
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00018668
|
9053 | MAP7, E-MAP-115, EMAP115 | microtubule-associated protein 7 |
C00018668
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00018668
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00018668
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00018668
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00018668
|
22919 | MAPRE1, EB1 | microtubule-associated protein, RP/EB family, member 1 |
C00018668
|
4147 | MATN2 | matrilin 2 |
C00018668
|
4155 | MBP | myelin basic protein |
C00018668
|
4192 | MDK, ARAP, MK, NEGF2 | midkine (neurite growth-promoting factor 2) |
C00018668
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00018668
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00018668
|
407040 | MIR34A, MIRN34A, miRNA34A, mir-34 | microRNA 34a |
C00018668
|
4311 | MME, CALLA, CD10, NEP, SFE | membrane metallo-endopeptidase (EC:3.4.24.11) |
C00018668
|
4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00018668
|
5891 | MOK, RAGE, RAGE-1, RAGE1 | MOK protein kinase (EC:2.7.11.22) |
C00018668
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00018668
|
4599 | MX1, IFI-78K, IFI78, MX, MxA | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
C00018668
|
29116 | MYLIP, IDOL, MIR | myosin regulatory light chain interacting protein (EC:6.3.2.-) |
C00018668
|
4651 | MYO10 | myosin X |
C00018668
|
4739 | NEDD9, CAS-L, CAS2, CASL, CASS2, HEF1 | neural precursor cell expressed, developmentally down-regulated 9 |
C00018668
|
4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00018668
|
9397 | NMT2 | N-myristoyltransferase 2 (EC:2.3.1.97) |
C00018668
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00018668
|
8204 | NRIP1, RIP140 | nuclear receptor interacting protein 1 |
C00018668
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00018668
|
55872 | PBK, CT84, Nori-3, SPK, TOPK | PDZ binding kinase (EC:2.7.12.2) |
C00018668
|
5111 | PCNA | proliferating cell nuclear antigen |
C00018668
|
23244 | PDS5A, SCC-112, SCC112 | PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
C00018668
|
8566 | PDXK, C21orf124, C21orf97, PKH, PNK | pyridoxal (pyridoxine, vitamin B6) kinase (EC:2.7.1.35) |
C00018668
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00018668
|
5569 | PKIA, PRKACN1 | protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
C00018668
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00018668
|
5354 | PLP1, GPM6C, HLD1, MMPL, PLP, PLP/DM20, PMD, SPG2 | proteolipid protein 1 |
C00018668
|
6490 | PMEL, D12S53E, ME20, ME20-M, ME20M, P1, P100, PMEL17, SI, SIL, SILV, gp100 | premelanosome protein |
C00018668
|
5376 | PMP22, CMT1A, CMT1E, DSS, GAS-3, HMSNIA, HNPP, Sp110 | peripheral myelin protein 22 |
C00018668
|
5447 | POR, CPR, CYPOR, P450R | P450 (cytochrome) oxidoreductase (EC:1.6.2.4) |
C00018668
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00018668
|
5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00018668
|
5621 | PRNP, ASCR, AltPrP, CD230, CJD, GSS, KURU, PRIP, PrP, PrP27-30, PrP33-35C, PrPc, p27-30 | prion protein |
C00018668
|
23215 | PRRC2C, BAT2-iso, BAT2D1, BAT2L2, XTP2 | proline-rich coiled-coil 2C |
C00018668
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00018668
|
64284 | RAB17 | RAB17, member RAS oncogene family |
C00018668
|
55647 | RAB20 | RAB20, member RAS oncogene family |
C00018668
|
5888 | RAD51, BRCC5, HRAD51, HsRad51, HsT16930, MRMV2, RAD51A, RECA | RAD51 recombinase |
C00018668
|
5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00018668
|
11186 | RASSF1, 123F2, NORE2A, RASSF1A, RDA32, REH3P21 | Ras association (RalGDS/AF-6) domain family member 1 |
C00018668
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00018668
|
5931 | RBBP7, RbAp46 | retinoblastoma binding protein 7 |
C00018668
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00018668
|
5983 | RFC3, RFC38 | replication factor C (activator 1) 3, 38kDa |
C00018668
|
5984 | RFC4, A1, RFC37 | replication factor C (activator 1) 4, 37kDa |
C00018668
|
6189 | RPS3A, FTE1, MFTL, S3A | ribosomal protein S3A |
C00018668
|
864 | RUNX3, AML2, CBFA3, PEBP2aC | runt-related transcription factor 3 |
C00018668
|
6281 | S100A10, 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1], GP11, P11, p10 | S100 calcium binding protein A10 |
C00018668
|
6282 | S100A11, MLN70, S100C | S100 calcium binding protein A11 |
C00018668
|
6275 | S100A4, 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98 | S100 calcium binding protein A4 |
C00018668
|
6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00018668
|
6447 | SCG5, 7B2, P7B2, SGNE1, SgV | secretogranin V (7B2 protein) |
C00018668
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00018668
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00018668
|
6446 | SGK1, SGK | serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1) |
C00018668
|
9467 | SH3BP5, SAB, SH3BP-5 | SH3-domain binding protein 5 (BTK-associated) |
C00018668
|
9120 | SLC16A6, MCT6, MCT7 | solute carrier family 16, member 6 |
C00018668
|
6505 | SLC1A1, EAAC1, EAAT3, SCZD18 | solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
C00018668
|
11000 | SLC27A3, ACSVL3, FATP3, VLCS-3 | solute carrier family 27 (fatty acid transporter), member 3 (EC:6.2.1.-) |
C00018668
|
10924 | SMPDL3A, ASM3A, ASML3a, yR36GH4.1 | sphingomyelin phosphodiesterase, acid-like 3A |
C00018668
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00018668
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00018668
|
10580 | SORBS1, CAP, FLAF2, R85FL, SH3D5, SH3P12, SORB1 | sorbin and SH3 domain containing 1 |
C00018668
|
6272 | SORT1, Gp95, LDLCQ6, NT3 | sortilin 1 |
C00018668
|
5552 | SRGN, PPG, PRG, PRG1 | serglycin |
C00018668
|
6426 | SRSF1, ASF, SF2, SF2p33, SFRS1, SRp30a | serine/arginine-rich splicing factor 1 |
C00018668
|
7982 | ST7, ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7 | suppression of tumorigenicity 7 |
C00018668
|
8614 | STC2, STC-2, STCRP | stanniocalcin 2 |
C00018668
|
10923 | SUB1, P15, PC4, p14 | SUB1 homolog (S. cerevisiae) |
C00018668
|
55638 | SYBU, GOLSYN, OCSYN, SNPHL | syntabulin (syntaxin-interacting) |
C00018668
|
81550 | TDRD3 | tudor domain containing 3 |
C00018668
|
7020 | TFAP2A, AP-2, AP-2alpha, AP2TF, BOFS, TFAP2 | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
C00018668
|
7033 | TFF3, ITF, P1B, TFI | trefoil factor 3 (intestinal) |
C00018668
|
7035 | TFPI, EPI, LACI, TFI, TFPI1 | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
C00018668
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00018668
|
23483 | TGDS, SDR2E1, TDPGD | TDP-glucose 4,6-dehydratase (EC:4.2.1.46) |
C00018668
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00018668
|
7045 | TGFBI, BIGH3, CDB1, CDG2, CDGG1, CSD, CSD1, CSD2, CSD3, EBMD, LCD1 | transforming growth factor, beta-induced, 68kDa |
C00018668
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00018668
|
80008 | TMEM156 | transmembrane protein 156 |
C00018668
|
27346 | TMEM97, MAC30 | transmembrane protein 97 |
C00018668
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00018668
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00018668
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00018668
|
7163 | TPD52, D52, N8L, PC-1, PrLZ, hD52 | tumor protein D52 |
C00018668
|
51499 | TRIAP1, MDM35, P53CSV, WF-1 | TP53 regulated inhibitor of apoptosis 1 |
C00018668
|
28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00018668
|
23321 | TRIM2, CMT2R, RNF86 | tripartite motif containing 2 |
C00018668
|
22059 |
C00018668
|
||
22062 |
C00018668
|
||
1890 | TYMP, ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF | thymidine phosphorylase (EC:2.4.2.4) |
C00018668
|
7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00018668
|
5412 | UBL3, HCG-1, PNSC1 | ubiquitin-like 3 |
C00018668
|
7345 | UCHL1, NDGOA, PARK5, PGP_9.5, PGP9.5, PGP95, Uch-L1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (EC:3.4.19.12) |
C00018668
|
7372 | UMPS, OPRT | uridine monophosphate synthetase (EC:2.4.2.10 4.1.1.23) |
C00018668
|
55062 | WIPI1, ATG18, ATG18A, WIPI49 | WD repeat domain, phosphoinositide interacting 1 |
C00018668
|
7474 | WNT5A, hWNT5A | wingless-type MMTV integration site family, member 5A |
C00018668
|
9589 | WTAP | Wilms tumor 1 associated protein |
C00018668
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00018668
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00018668
|
7518 | XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 |
C00018668
|
23528 | ZNF281, ZBP-99, ZNP-99 | zinc finger protein 281 |
C00018668
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00018665
C00018668 |
D010190 | Pancreatic Neoplasms |
C00018668
|
D000230 | Adenocarcinoma |
C00018668
|
C538231 | Adenocarcinoma of lung |
C00018668
|
D000740 | Anemia |
C00018668
|
D000741 | Anemia, Aplastic |
C00018668
|
D000743 | Anemia, Hemolytic |
C00018668
|
D001002 | Anuria |
C00018668
|
D001005 | Anus Neoplasms |
C00018668
|
D001167 | Arteritis |
C00018668
|
D001259 | Ataxia |
C00018668
|
D001284 | Atrophy |
C00018668
|
D053099 | Azotemia |
C00018668
|
D001649 | Bile Duct Diseases |
C00018668
|
D001855 | Bone Marrow Diseases |
C00018668
|
D001943 | Breast Neoplasms |
C00018668
|
D002114 | Calcinosis |
C00018668
|
D002277 | Carcinoma |
C00018668
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00018668
|
D002294 | Carcinoma, Squamous Cell |
C00018668
|
D002295 | Carcinoma, Transitional Cell |
C00018668
|
D016893 | Carotid Stenosis |
C00018668
|
D002386 | Cataract |
C00018668
|
D002637 | Chest Pain |
C00018668
|
D002764 | Cholecystitis |
C00018668
|
D002921 | Cicatrix |
C00018668
|
D003110 | Colonic Neoplasms |
C00018668
|
D015179 | Colorectal Neoplasms |
C00018668
|
D003231 | Conjunctivitis |
C00018668
|
D003316 | Corneal Diseases |
C00018668
|
C535474 | Corneal dystrophy Avellino type |
C00018668
|
D015715 | Corneal Edema |
C00018668
|
D003318 | Corneal Opacity |
C00018668
|
D057112 | Corneal Perforation |
C00018668
|
D017577 | Cutaneous Fistula |
C00018668
|
D003556 | Cystitis |
C00018668
|
D003711 | Demyelinating Diseases |
C00018668
|
D003967 | Diarrhea |
C00018668
|
D018450 | Disease Progression |
C00018668
|
D004342 | Drug Hypersensitivity |
C00018668
|
D004427 | Ear Diseases |
C00018668
|
D004487 | Edema |
C00018668
|
D004802 | Eosinophilia |
C00018668
|
D004890 | Erythema |
C00018668
|
D004938 | Esophageal Neoplasms |
C00018668
|
C562729 | Esophageal Squamous Cell Carcinoma |
C00018668
|
D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00018668
|
D005221 | Fatigue |
C00018668
|
D005334 | Fever |
C00018668
|
D005355 | Fibrosis |
C00018668
|
D005770 | Gastrointestinal Neoplasms |
C00018668
|
D005901 | Glaucoma |
C00018668
|
D005902 | Glaucoma, Open-Angle |
C00018668
|
D005909 | Glioblastoma |
C00018668
|
D006258 | Head and Neck Neoplasms |
C00018668
|
D006333 | Heart Failure |
C00018668
|
D006417 | Hematuria |
C00018668
|
D006461 | Hemolysis |
C00018668
|
D006463 | Hemolytic-Uremic Syndrome |
C00018668
|
D006470 | Hemorrhage |
C00018668
|
D006504 | Hepatic Veno-Occlusive Disease |
C00018668
|
D006869 | Hydronephrosis |
C00018668
|
D006932 | Hyperbilirubinemia |
C00018668
|
D006947 | Hyperkalemia |
C00018668
|
D006973 | Hypertension |
C00018668
|
D006994 | Hypoaldosteronism |
C00018668
|
D007008 | Hypokalemia |
C00018668
|
D007010 | Hyponatremia |
C00018668
|
D045823 | Ileus |
C00018668
|
D007238 | Infarction |
C00018668
|
D007412 | Intestinal Fistula |
C00018668
|
D007499 | Iris Diseases |
C00018668
|
D007500 | Iritis |
C00018668
|
D007673 | Kidney Cortex Necrosis |
C00018668
|
D007674 | Kidney Diseases |
C00018668
|
D007676 | Kidney Failure, Chronic |
C00018668
|
D007970 | Leukopenia |
C00018668
|
D008113 | Liver Neoplasms |
C00018668
|
D008171 | Lung Diseases |
C00018668
|
D008175 | Lung Neoplasms |
C00018668
|
D052016 | Mucositis |
C00018668
|
D009102 | Multiple Organ Failure |
C00018668
|
D009325 | Nausea |
C00018668
|
D009336 | Necrosis |
C00018668
|
D009362 | Neoplasm Metastasis |
C00018668
|
D009369 | Neoplasms |
C00018668
|
D009422 | Nervous System Diseases |
C00018668
|
D020258 | Neurotoxicity Syndromes |
C00018668
|
D009503 | Neutropenia |
C00018668
|
D015814 | Ocular Hypotension |
C00018668
|
D009846 | Oliguria |
C00018668
|
D010051 | Ovarian Neoplasms |
C00018668
|
D010146 | Pain |
C00018668
|
D010167 | Pallor |
C00018668
|
D058186 | Acute Kidney Injury |
C00018668
|
D017699 | Pelvic Pain |
C00018668
|
D020795 | Photophobia |
C00018668
|
D011183 | Postoperative Complications |
C00018668
|
D011471 | Prostatic Neoplasms |
C00018668
|
D011625 | Pterygium |
C00018668
|
D011654 | Pulmonary Edema |
C00018668
|
D011668 | Pulmonary Veno-Occlusive Disease |
C00018668
|
D011681 | Pupil Disorders |
C00018668
|
D011697 | Purpura, Thrombotic Thrombocytopenic |
C00018668
|
D012004 | Rectal Neoplasms |
C00018668
|
D012008 | Recurrence |
C00018668
|
D051437 | Renal Insufficiency |
C00018668
|
D015356 | Retinal Artery Occlusion |
C00018668
|
D012170 | Retinal Vein Occlusion |
C00018668
|
D015422 | Scleral Diseases |
C00018668
|
D012871 | Skin Diseases |
C00018668
|
D012883 | Skin Ulcer |
C00018668
|
D013274 | Stomach Neoplasms |
C00018668
|
D013280 | Stomatitis |
C00018668
|
D013921 | Thrombocytopenia |
C00018668
|
D013927 | Thrombosis |
C00018668
|
D014517 | Ureteral Obstruction |
C00018668
|
D001745 | Urinary Bladder Diseases |
C00018668
|
D001747 | Urinary Bladder Fistula |
C00018668
|
D001749 | Urinary Bladder Neoplasms |
C00018668
|
D014555 | Urination Disorders |
C00018668
|
D014652 | Vascular Diseases |
C00018668
|
D019043 | Vascular Neoplasms |
C00018668
|
D014719 | Vesicovaginal Fistula |
C00018668
|
D014786 | Vision Disorders |
C00018668
|
D014839 | Vomiting |
C00018668
|
D014947 | Wounds and Injuries |
C00018668
|